• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Senate Agreement on COVID-19 Legislative and Funding Package


AMGA appreciates Congress’ efforts during this critical situation and will continue to work with key House and Senate leaders to ensure the federal response to COVID-19 is informed by the experience and recommendations of our members, who are responsible for the care of one in three Americans.

March 25, 2020 — Alexandria, VA – Today, the Senate reached agreement on a legislative package that includes critical funding to address the shortage of personal protective equipment (PPE) that AMGA members need to care for patients during this public health emergency. AMGA members are on the frontlines of combatting the novel coronavirus (COVID-19) and any shortage of crucial supplies, such as N95 masks, will compromise their ability to treat patients and prevent further spread of the virus. AMGA’s membership is ready to work with federal, state, and local officials to obtain these needed supplies as soon as possible.

The Senate package also includes $100 billion for healthcare providers to respond to COVID-19. H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and an accompanying emergency appropriations package provides funding to cover lost revenues that result from this pandemic. AMGA members are working diligently to treat their patients while keeping their providers and community as safe as possible.

As part of their COVID-19 response, AMGA members have cancelled their elective surgeries and procedures and are encouraging their patients to stay home. The CARES Act recognizes the significant financial challenges this creates for group practices and integrated health systems.

Read the full press release here.

Related Videos
Chase D. Hendrickson, MD, MPH
Takiyah Durham, MBA, and Margaret Larkins-Pettigrew, MD
Afreen Idris Shariff, MD, MBBS, Duke Cancer Institute
 Brian Mullen, PhD, head of innovation and product, The Clinic by Cleveland Clinic
Mike Koroscik, MBA, MHA, Allina Health and the Allina Health Cancer Institute
Ted Okon, MBA, Community Oncology Alliance
dr erin gillaspie
Miriam J. Atkins, MD, FACP, Community Oncology Alliance/AO Multispecialty Clinic
Lalan Wilfongd, MD, US Oncology Network
Related Content
© 2023 MJH Life Sciences
All rights reserved.